Lilly’s stock tumbled as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
www.marketwatch.com
#Eli #Lillys #weightloss #pill #didnt #work #stock #plunging
Related Posts
Major events in the history of French fashion group Kering
(Reuters) -Gucci owner Kering is reported to be close to appointing Renault’s ex-boss Luca de Meo as its new CEO.…

Warren Buffett announces $6 billion in donations to five foundations
NEW YORK (AP) — Famed investor Warren Buffett is donating $6 billion worth of his company’s stock to five foundations,…

Why Argan Stock Soared This Week
A shift in investor thinking has been hitting the “Magnificent Seven” big tech stocks recently, as investors wonder whether they…

